Clinical Trial Update: Adebrelimab + Apatinib in SCLC Maintenance Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of adebrelimab and apatinib as maintenance therapy for small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)

Snippet

Sponsor: Tang-Du Hospital | Conditions: SCLC | Phase 2 | Status: RECRUITING